The UW Health | Carbone Cancer Center and UW Program for Advanced Cell Therapy, or PACT, will soon begin a clinical trial using a recently developed cell therapy to treat severe dry mouth....
New initiatives at UW Health seek to highlight and streamline patient access to individualized, data-driven cancer care....
The UW Clinical Trials Institute (CTI) will implement a budget template in support of a consistent clinical trials budgeting experience for industry sponsors across SMPH and UW Health....
Investigators will be assessing the use of the drug to treat impaired social motivation, or asociality, which is a symptom of schizophrenia that can cause significant functional impairment....
According to UW–Madison geriatrician Nathaniel Chin, "We are on a trajectory for prevention."...
UW Health and the UW School of Medicine and Public Health (SMPH) have convened a new committee to help centralize and streamline the clinical trials review process at UW–Madison....
With new support from the National Institutes of Health, a team of researchers at the Wisconsin Institute of Discovery will lead drug therapeutics testing for two diseases known to cause blindness....
A drug used in people in the early stage of the most common kind of breast cancer – HR+/HER2- breast cancer – significantly reduced the risk of the cancer returning after treatment, according to a new study....
University of Wisconsin Carbone Cancer Center will be designated as a Specialized Program of Research Excellence, or SPORE, by the National Cancer Institute (NCI) for research initiatives to advance new prostate cancer treatments....
Researchers with the UW Carbone Cancer Center are developing AI techniques to improve personalized treatments for brain cancer and to avoid unnecessary biopsies and surgeries....
